NCT00515879View on ClinicalTrials.gov

Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia

PHASE3CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Social Anxiety Disorder
Interventions
DRUG

D-cycloserine

50 mg

BEHAVIORAL

Cognitive behavioral therapy (CBT)

CBT sessions aim to help participants become more comfortable with social situations.

DRUG

Placebo

Same dosage as active pill

Trial Locations (1)

02215

Boston University, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Boston University Charles River Campus

OTHER

NCT00515879 - Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia | Biotech Hunter | Biotech Hunter